References
- Ahmed SM, Abdel-Rahman AA, Saleh SI, Ahmed MO (1993): Comparative dissolution characteristics of bropirimine-beta-cyclodextrin inclusion complex and its solid dispersions with PEG-6000. Int J Pharm 96: 5–11.
- Ammar HO, Ghorab M, El-Nahhas SA, Makram TS (1997): Interaction of oral anticoagulants with methyl xanthines. Pharmazie 52: 946–950.
- Baboota S, Shakeel F, Ahuja A, Ali J, Shafiq S (2007a): Design development and evaluation of novel nanoemulsion formulation for transdermal potential of celecoxib. Acta Pharm 8: 316–332.
- Baboota S, Shakeel F, Ahuja A, Ali J, Ahmed S, Shafiq S (2007b): Development and validation of a stability-indicating HPLC method for analysis of celecoxib in bulk drug and microemulsion formulations. Acta Chromatogr 18: 116–129.
- Estigneev MP, Khomich VV, Davies DB (2006a): Complexation of anthracyclines with DNA in the presence of caffeine. Eur Biophys J 36: 1–11.
- Estigneev MP, Rybacova KA, Davies DB (2006b): Complexation of norfloxacin with DNA in the presence of caffeine. Biophys Chem 121: 84–95.
- Fisher SM, Lo HH, Gordon GB, Seibert K, Kellof G, Lubet RA, Conti CJ (1999): Chemopreventive activity of celecoxib, a specific cyclo-oxygenase inhibitor and indomethacin against ultraviolet light induced skin carcinogenesis. Mol Carcinog 25: 231–240.
- Hampp A (1996): The extraction of caffeine from tea: a modification of procedure of Murray and Hansen. J Chem Educ 73: 1112.
- Harris RE, Alshafie GA, Asbou-Issa H, Seibert K (2000): Chemoprevention of breast cancer in rats by celecoxib, a specific cyclo-oxygenase inhibitor. Cancer Res 60: 2101–2103.
- Kawamori T, Rao CV, Seibert K, Reddy BS (1998): Chemopreventive activity of celecoxib, a specific cyclo-oxygenase inhibitor against colon cancer. Cancer Res 58: 409–412.
- Leiberman HR, Wurtman RJ, Emde GG, Coviella ILG (1987): The effects of caffeine and aspirin on mood and performance. J Clin Psycopharmacol 7: 315–320.
- Michal S, Andrzej S (2008): Modulation of cellular response to anticancer treatment by caffeine: inhibition of cell cycle checkpoints, DNA repair and more. Curr Pharm Biotech 9: 325–336.
- Murray DS, Hansen PJ (1995): Extraction of caffeine from tea: an old undergraduate experiment revisited. J Chem Educ 72: 851–852.
- Popli H, Murthy RS, Miglani BD (1994): Solid dispersions as a drug delivery system for sulfamethoxazole and nitrofurantoin. Ind J Hosp Pharm 31: 97–100.
- Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM, Abraham RT (1999): Inhibition of ATM and ATR kinase activities by radiosensitizing agent caffeine. Cancer Res 59: 4375–4382.
- Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S (2008a): Celecoxib nanoemulsion: Skin permeation mechanism and bioavailability assessment. J Drug Target 16: 733–740.
- Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S (2008b): Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J Nanobiotechnol 6: E8.
- Tomita K, Tsuchiya H (2008): Caffeine enhancement of the effect of anticancer agents on human sarcoma cells. Cancer Sci 80: 83–88.